Literature DB >> 24889208

Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center.

Robert L Satcher1, Oliver Bogler, Laurel Hyle, Andrew Lee, Angela Simmons, Robert Williams, Ernest Hawk, Surena Matin, Abenaa M Brewster.   

Abstract

BACKGROUND: Despite the growing incidence of cancer worldwide, there are an insufficient number of primary care physicians, community oncologists, and surgeons to meet the demand for cancer care, especially in rural and other medically underserved areas. Teleoncology, including diagnostics, treatment, and supportive care, has the potential to enhance access to cancer care and to improve clinician education and training.
OBJECTIVES: Major cancer centers such as The University of Texas MD Anderson Cancer Center must determine how teleoncology will be used as part of strategic planning for the future. The Telemedicine and Telesurgery in Cancer Care (TTCC) conference was convened to determine technologically based strategies for addressing global access to essential cancer care services.
RESULTS: The TTCC conference brought policy makers together with physicians, legal and regulatory experts to define strategies to optimize available resources, including teleoncology, to advance global cancer care.
CONCLUSIONS: The TTCC conference discourse provided insight into the present state of access to care, expertise, training, technology and other interventions, including teleoncology, currently available through MD Anderson, as well as a vision of what might be achievable in the future, and proposals for moving forward with a comprehensive strategy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; telemedicine; teleoncology; telesurgery

Mesh:

Year:  2014        PMID: 24889208     DOI: 10.1002/jso.23652

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

Review 1.  Promise of Mobile Health Technology to Reduce Disparities in Patients With Cancer and Survivors.

Authors:  Brian D Gonzalez
Journal:  JCO Clin Cancer Inform       Date:  2018-12

2.  Factors Influencing Telemedicine Use at a Northern New England Cancer Center During the COVID-19 Pandemic.

Authors:  Matthew B Mackwood; Tor D Tosteson; Jennifer A Alford-Teaster; Kevin M Curtis; Mary L Lowry; Jennifer A Snide; Wenyan Zhao; Anna N A Tosteson
Journal:  JCO Oncol Pract       Date:  2022-04-21

3.  Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.

Authors:  Lindsey A McAlarnen; Shirng-Wern Tsaih; Rana Aliani; Natasha M Simske; Elizabeth E Hopp
Journal:  Gynecol Oncol       Date:  2021-05-11       Impact factor: 5.304

Review 4.  Telemedicine Applications in the Era of COVID-19: Telesurgery Issues.

Authors:  Paolo Bailo; Filippo Gibelli; Alberto Blandino; Andrea Piccinini; Giovanna Ricci; Ascanio Sirignano; Riccardo Zoja
Journal:  Int J Environ Res Public Health       Date:  2021-12-29       Impact factor: 3.390

5.  Establishment of a new practical telesurgical platform using the hinotori™ Surgical Robot System: a preclinical study.

Authors:  Masaya Nakauchi; Koichi Suda; Kenichi Nakamura; Tsuyoshi Tanaka; Susumu Shibasaki; Kazuki Inaba; Tatsuhiko Harada; Masanao Ohashi; Masayuki Ohigashi; Hiroaki Kitatsuji; Shingo Akimoto; Kenji Kikuchi; Ichiro Uyama
Journal:  Langenbecks Arch Surg       Date:  2022-10-14       Impact factor: 2.895

Review 6.  Telesurgery: Past, Present, and Future.

Authors:  Paul J Choi; Rod J Oskouian; R Shane Tubbs
Journal:  Cureus       Date:  2018-05-31

7.  Factors Affecting Use of Telemedicine and Telesurgery in Cancer Care (TTCC) among Specialist Physicians

Authors:  Mohammadreza Maleki; Seyed Masood Mousavi; Omid Khosravizadeh; Mohammad Heidari; Mehdi Raadabadi; Mina Jahanpour
Journal:  Asian Pac J Cancer Prev       Date:  2018-11-29

8.  Preparing Medical Specialists for Genomic Medicine: Continuing Education Should Include Opportunities for Experiential Learning.

Authors:  Belinda J McClaren; Erin Crellin; Monika Janinski; Amy E Nisselle; Larissa Ng; Sylvia A Metcalfe; Clara L Gaff
Journal:  Front Genet       Date:  2020-03-03       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.